Angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARB), and beta blockers should be used presymptomatically to prevent cardiomyopathy in DMD patients (McNally, 2007, 2017; Buddhe et al., 2018; Bourke et al., 2019). Here, ACE is linked to Duchenne muscular dystrophy.